Literature DB >> 28608475

The natural history of recoverable vocal fold paralysis: Implications for kinetics of reinnervation.

Ted Mau1, Hao-Min Pan1, Lesley F Childs1.   

Abstract

OBJECTIVES/HYPOTHESIS: Patients with unilateral vocal fold paralysis (UVFP) are commonly told to wait 12 months for spontaneous recovery. This study aims to 1) determine the time to vocal recovery in UVFP, 2) use that data to develop a neurophysiologically plausible model for recovery, and 3) use the model to generate meaningful predictions for patient counseling. STUDY
DESIGN: Case series with de novo mathematical modeling.
METHODS: Patients with UVFP who could pinpoint a discrete onset of vocal improvement were identified. The time-to-recovery data were modeled by assuming an "early" recovery group with neuropraxia and a "late" recovery group with more severe nerve injury. For the late group, a two-stage model was developed to explain the time to recovery: regenerating axons must cross the site of injury in stage 1 (probabilistic), followed by unimpeded regrowth to the larynx in stage 2 (deterministic).
RESULTS: Of 727 cases of UVFP over a 7-year period, 44 reported spontaneous recovery with a discrete onset of vocal improvement. A hybrid distribution incorporating the two stages (exponentially modified Gaussian) accurately modeled the time-to-recovery data (R2 = 0.918). The model predicts 86% of patients with recoverable UVFP will recover within 6 months, with 96% recovering within 9 months. Earlier vocal recovery is associated with recovery of vocal fold motion and younger age.
CONCLUSIONS: Waiting 12 months for spontaneous recovery is probably too conservative. Repair across the site of injury, and not regrowth to larynx, is likely the rate-determining step in reinnervation, consistent with other works on peripheral nerve regeneration. LEVEL OF EVIDENCE: 4. Laryngoscope, 127:2585-2590, 2017.
© 2017 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  Laryngeal reinnervation; ex-Gaussian; peripheral nerve regeneration; recurrent laryngeal nerve; vocal fold paralysis

Mesh:

Year:  2017        PMID: 28608475     DOI: 10.1002/lary.26734

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  7 in total

1.  Analysis of Dysphagia and Cough Strength in Patients with Unilateral Vocal Fold Paralysis.

Authors:  Kazutaka Kashima; Kenichi Watanabe; Takeshi Sato; Yukio Katori
Journal:  Dysphagia       Date:  2021-03-17       Impact factor: 3.438

2.  Natural Course of Unilateral Vocal Fold Paralysis and Optimal Timing of Permanent Treatment.

Authors:  Dong-Han Lee; Sang-Youp Lee; Minhyung Lee; Jungirl Seok; Sung Joon Park; Young Ju Jin; Doh Young Lee; Tack-Kyun Kwon
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2020-01-01       Impact factor: 6.223

3.  Long-term quality of voice is usually acceptable after initial hoarseness caused by a thyroidectomy or a parathyroidectomy.

Authors:  Ioannis Christakis; Patrick Klang; Nadia Talat; Gabriele Galata; Klaus-Martin Schulte
Journal:  Gland Surg       Date:  2019-06

4.  Superomedial partial arytenoidectomy for voice improvement by correction of posterior glottic insufficiency.

Authors:  Rutger Mahieu; Derrek Heuveling; Hans Mahieu
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-02-18       Impact factor: 2.503

Review 5.  Selective Electrical Surface Stimulation to Support Functional Recovery in the Early Phase After Unilateral Acute Facial Nerve or Vocal Fold Paralysis.

Authors:  Annabella Kurz; Gerd Fabian Volk; Dirk Arnold; Berit Schneider-Stickler; Winfried Mayr; Orlando Guntinas-Lichius
Journal:  Front Neurol       Date:  2022-04-04       Impact factor: 4.086

Review 6.  Surgery for bilateral vocal fold paralysis: Systematic review and meta-analysis.

Authors:  Kai Titulaer; Peter Schlattmann; Orlando Guntinas-Lichius
Journal:  Front Surg       Date:  2022-07-22

7.  Care and Management of Voice Change in Thyroid Surgery: Korean Society of Laryngology, Phoniatrics and Logopedics Clinical Practice Guideline.

Authors:  Chang Hwan Ryu; Seung Jin Lee; Jae-Gu Cho; Ik Joon Choi; Yoon Seok Choi; Yong Tae Hong; Soo Yeon Jung; Ji Won Kim; Doh Young Lee; Dong Kun Lee; GIljoon Lee; Sang Joon Lee; Young Chan Lee; Yong Sang Lee; Inn Chul Nam; Ki Nam Park; Young Min Park; Eui-Suk Sung; Hee Young Son; In Hyo Seo; Byung-Joo Lee; Jae-Yol Lim
Journal:  Clin Exp Otorhinolaryngol       Date:  2021-06-01       Impact factor: 3.372

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.